Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions-Reference-Cited by-同舟云学术

Factors associated with guideline-based hepatitis C virus (HCV) treatment initiation in HIV/HCV-coinfected patients: role of comorbidities and physicians' perceptions

Published:2013-03-05 Issue:7 Volume:14 Page:430-436
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Winnock M¹,Bani-Sadr F²,Pambrun E¹,Loko M-A¹,Carrieri P³,Neau D⁴,Morlat P⁵,Marchou B⁶,Dabis F¹,Salmon D²,

Affiliation:

1. Bordeaux University; ISPED; INSERM U897; Bordeaux; France

2. Department of Infectious Diseases; Robert Debré hospital; University of Champagne Ardenne; Reims; France

3. INSERM; U912 (SE4S)-University of Aix Marseille; IRD; UMR-S912-ORS PACA; Marseille; France

4. Department of Infectious Diseases; Pellegrin hospital; Bordeaux; France

5. Department of Internal Medicine; CHU Bordeaux; University of Bordeaux Segalen; INSERM U 897; Bordeaux; France

6. Department of Infectious Diseases; Purpan hospital; Toulouse; France

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference24 articles.

1. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors;Bani-Sadr;Clin Infect Dis,2008

2. Impact of HAART exposure and associated lipodystrophy on advanced liver fibrosis in HIV/HCV-coinfected patients;Loko;J Viral Hepat,2011

3. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: the French national Mortalite 2005 study;Salmon-Ceron;J Hepatol,2009

4. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial;Carrat;JAMA,2004

5. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients;Torriani;N Engl J Med,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States;Preventive Medicine Reports;2023-04

2. Clinician Barriers, Perceptions, and Practices in Treating Patients with Hepatitis C Virus and Substance Use Disorder;SSRN Electronic Journal;2022

3. Racial-Ethnic Disparities in Uptake of New Hepatitis C Drugs in Medicare;Journal of Racial and Ethnic Health Disparities;2016-12-07

4. All-oral Direct-acting Antiviral Regimens in HIV/Hepatitis C Virus–coinfected Patients With Cirrhosis Are Efficient and Safe: Real-life Results From the Prospective ANRS CO13–HEPAVIH Cohort;Clinical Infectious Diseases;2016-06-17

5. HCV treatment in children and young adults with HIV/HCV co-infection in Europe;Journal of Virus Eradication;2015-07